Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia

被引：0
|
作者：
Khan, Khurshid Ahmed [1 ]
Junaid, Ayesha [2 ]
Siddiqui, Nauman Saleem
Mukhtar, Khalida [3 ]
Siddiqui, Saleem [3 ]
机构：
[1] Natl Oncol Res Inst, Dept Oncol, Islamabad, Pakistan
[2] Shifa Int Hosp, Dept Pathol, Islamabad, Pakistan
[3] Shifa Int Hosp, Dept Haematol & Oncol, Islamabad, Pakistan
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2008年 / 18卷 / 03期
关键词：
imatinib; chronic myeloid leukemia; bone marrow aplasia;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We are reporting a case of imatinib-related fatal bone marrow aplasia after complete cytogenetic response.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [41] Effect of allogenic bone marrow transplantation in patients with acute leukemia in complete remission and with chronic myeloid leukemia in a chronic phase
    Lyubimova, LS
    Savchenko, VG
    Mendeleeva, LP
    Klyasova, GA
    Gribanova, EO
    Demidova, IA
    Galtseva, IV
    Kuzmina, LA
    Momotyuk, KS
    Kuliev, RG
    Zotikov, EA
    Poreshina, LP
    Kutyina, RM
    Vasilyeva, MN
    Glasko, EN
    Shpakova, AP
    Kalinin, NN
    Olshanskaya, YV
    Pavlova, OA
    Vinogradova, OA
    TERAPEVTICHESKII ARKHIV, 1999, 71 (07) : 27 - 32
  • [42] Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib
    Carulli, Giovanni
    Cannizzo, Elisa
    Ottaviano, Virginia
    Cervetti, Giulia
    Buda, Gabriele
    Galimberti, Sara
    Barate, Claudia
    Marini, Alessandra
    Petrini, Mario
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1336 - 1339
  • [43] Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib
    Ganguly, Sandip
    Lakshmaiah, K. C.
    Jacob, Linu Abraham
    Babu, Suresh
    Dasappa, Lokanatha
    Babu, K. S. Govind
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (01) : 82 - 86
  • [44] Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib
    Sandip Ganguly
    K. C. Lakshmaiah
    Linu Abraham Jacob
    Suresh Babu
    Lokanatha Dasappa
    K. S. Govind Babu
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 82 - 86
  • [45] Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation
    Watanabe, Mirea
    Marumo, Atsushi
    Onai, Daishi
    Li, Meya
    Kaito, Yuta
    Asayama, Toshio
    Yui, Shunsuke
    Nagata, Yasunobu
    Wakita, Satoshi
    Yamaguchi, Hiroki
    INTERNAL MEDICINE, 2025,
  • [46] The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure
    Jabbour, Elias
    Kantarjian, Hagop
    Ghanem, Hady
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Garcia-Manero, Guillermo
    Cardenas, Marylou
    Cortes, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03) : 302 - 306
  • [47] Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?
    Song, Moo-Kon
    Chung, Joo-Seop
    Seol, Young-Mi
    Kim, Seong-Geun
    Shin, Ho-Jin
    Choi, Young-Jin
    Cho, Goon-Jae
    LEUKEMIA RESEARCH, 2009, 33 (11) : 1459 - 1462
  • [48] Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia
    Kallel, Faten
    Kassar, Olfa
    Maaloul, Imen
    Charfi, Maha
    Ksouda, Kamilia
    Elloumi, Moez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1762 - 1765
  • [49] Allogeneic bone marrow transplantation for chronic myeloid leukemia
    Gratwohl, A
    Hermans, J
    BONE MARROW TRANSPLANTATION, 1996, 17 : S7 - S9
  • [50] KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
    Marin, D.
    Gabriel, I. H.
    Ahmad, S.
    Foroni, L.
    de Lavallade, H.
    Clark, R.
    O'Brien, S.
    Sergeant, R.
    Hedgley, C.
    Milojkovic, D.
    Khorashad, J. S.
    Bua, M.
    Alsuliman, A.
    Khoder, A.
    Stringaris, K.
    Cooper, N.
    Davis, J.
    Goldman, J. M.
    Apperley, J. F.
    Rezvani, K.
    LEUKEMIA, 2012, 26 (02) : 296 - 302
12345